A list of the major pharma players looking for solutions to tackle the pandemic.
While most of the global population is under lockdown to prevent the spread of the coronavirus, many laboratories in the pharma industry are striving to tackle the pandemic.
Some companies are repurposing or developing treatment, others are focusing on vaccines, tests or technology to deliver drugs in the body.
Existing drugs being repurposed:
- Gilead Sciences Inc’s (NASDAQ:GILD) antiviral medication remdesivir is undergoing the final phase of clinical trials, with results expected by the beginning of May.